Heart failure drugs beneficial even in presence of kidney disease
[PRESS RELEASE, 23 MAY 2015] A novel study from Karolinska Institutet in Sweden suggests that RAS-antagonists, common drugs for patients with heart failure, may benefit also patients who have concomitant kidney disease, a group previously not studied. The findings are being presented today at the annual congress of European heart failure specialists in Seville, Spain.These drugs have proven effect in heart failure, but patients with kidney disease were excluded from clinical trials due to fear of kidney complications. While kidney complications are still a potential concern, this new study,